Ostrum Asset Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Ostrum Asset Management's JNJ Position: Q3 2026 in Review
Ostrum Asset Management reduced its Johnson & Johnson (JNJ) stake by 6.6% in Q3 2026, selling an estimated $968K and leaving 52,068 shares worth $13.8M. The position accounts for 0.67% of the portfolio, ranked #28.
Ostrum Asset Management first reported a position in JNJ in Q1 2023 and has held it in 15 quarters since. The position peaked at $14.8M in Q4 2025. 4,243 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.
- Ostrum Asset Management held 52,068 shares of Johnson & Johnson worth $13.8M as of Q3 2026.
- Ostrum Asset Management sold 3,669 Johnson & Johnson shares in Q3 2026, an estimated $968K.
- Johnson & Johnson made up 0.67% of Ostrum Asset Management's portfolio in Q3 2026, its #28 holding.
- Ostrum Asset Management first reported a position in Johnson & Johnson in Q1 2023 and has held it in 15 quarters since.
- Ostrum Asset Management's Johnson & Johnson position peaked at $14.8M in Q4 2025.
- 4,243 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.
Based on Ostrum Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.